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Background: Bronchopulmonary dysplasia (BPD) is a common complication of preterm birth. Very different models
using clinical parameters at an early postnatal age to predict BPD have been developed with little extensive
quantitative validation. The objective of this study is to review and validate clinical prediction models for BPD.
Methods: We searched the main electronic databases and abstracts from annual meetings. The STROBE instrument
was used to assess the methodological quality. External validation of the retrieved models was performed using an
individual patient dataset of 3229 patients at risk for BPD. Receiver operating characteristic curves were used to
assess discrimination for each model by calculating the area under the curve (AUC). Calibration was assessed for the
best discriminating models by visually comparing predicted and observed BPD probabilities.
Results: We identified 26 clinical prediction models for BPD. Although the STROBE instrument judged the quality
from moderate to excellent, only four models utilised external validation and none presented calibration of the
predictive value. For 19 prediction models with variables matched to our dataset, the AUCs ranged from 0.50 to
0.76 for the outcome BPD. Only two of the five best discriminating models showed good calibration.
Conclusions: External validation demonstrates that, except for two promising models, most existing clinical
prediction models are poor to moderate predictors for BPD. To improve the predictive accuracy and identify
preterm infants for future intervention studies aiming to reduce the risk of BPD, additional variables are required.
Subsequently, that model should be externally validated using a proper impact analysis before its clinical
implementation.
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Over recent decades, advances in neonatal care have im-
proved survival amongst very preterm infants, but high
rates of morbidity remain [1,2]. Bronchopulmonary dyspla-
sia (BPD) is one of the most important complications of
preterm birth and is associated with the long lasting bur-
dens of pulmonary and neurodevelopmental sequelae [3-5].* Correspondence: w.onland@amc.uva.nl
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reproduction in any medium, provided the orMany interventions to reduce the risk of BPD have
been tested in randomized clinical trials (RCTs), but only
a few have shown significant treatment effects [6,7]. One
of the possible explanations for these disappointing re-
sults may be the poor ability to predict the risk of BPD
at an early stage in life, thereby failing to identify and in-
clude in RCTs those patients who will benefit most from
interventions that may reduce the risk of BPD.
Developing, validating and implementing prognostic
models are important as this provides clinicians with
more objective estimates of the probability of a diseaseLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ical information [8-11]. In neonatology, several studies
have developed clinical prediction models, using logistic
regression or consensus, to predict which preterm born
infants are most likely to develop BPD [12-14]. These
studies determined risk factors in a heterogeneous popu-
lation of patients by using various clinical and respira-
tory parameters at different postnatal ages. Quantifying
the predictive ability of these models in other preterm
populations that were not used in the model development,
often referred to as external validation of prediction
models, is rarely performed. Perhaps as a consequence,
none of these models have yet been implemented in clin-
ical care to guide patient management, or used in RCTs
that test interventions aimed to reduce BPD.
The primary aim of this study was to systematically re-
view all existing clinical prediction models for BPD in
the international literature, and subsequently validate
these models in a large external cohort of preterm in-
fants to determine which model yields the best predic-
tion of BPD in very preterm infants.
Methods
Search methods for study identification
In April 2012, two reviewers (WO and MM) identified
eligible prediction models for BPD in preterm infants
using a sensitive electronic search strategy of MEDLINE,
EMBASE and CINAHL. The precise search query is pre-
sented in Appendix.
The ‘prediction model’ part of this search query was
rerun using a recently published highly specific and sen-
sitive search filter [15]. We compared the yield of the
original search with the rerun using this search filter in
terms of citations missed and number needed to read,
defined as number of citations divided by the number of
eventually included research papers describing a unique
study.
Included reports and the abstracts of the Pediatric
Academic Societies (PAS) and the European Society for
Pediatric Research (ESPR) from 1990 onwards were
hand searched for additional studies not found by the
initial computerized search.
Criteria for considering studies for this review
To be included in the review, the study had to meet the
following criteria: (1) it described a clinical prediction
model for BPD; (2) the purpose of the model was to pre-
dict BPD in preterm infants using clinical information
from the first week of life; (3) the selected predictors used
were universally accessible parameters such as patient
characteristics (e.g. birth weight and gestational age), re-
spiratory support (either ventilator or non-invasive support)
or blood gases. Those studies investigating the prognostic
use of pulmonary function testing, ultrasonographyor radiographic testing, and measurements of tracheal
markers were excluded.
Data extraction and management
The following data from all included validation and der-
ivation studies were extracted independently by two re-
viewers (WO and MM): year of publication, region of
origin, number of hospitals including patients for the
derivation cohort, type of data collection (e.g. retrospect-
ive or prospective), period of data collection, number of
predictors, patient characteristics (i.e. birth weight, ges-
tational age, gender, inclusion of non-ventilated pa-
tients), on which postnatal day the original model was
developed or validated, and the definition of BPD [e.g.
oxygen dependency 28 days postnatal age (PNA) or at
36 weeks postmenstrual age (PMA)], the number of pa-
tients used for derivation of the model (not applicable
for the validation studies) and the number of patients
for internal and external validation when performed in
the study.
The following additional items specific to the develop-
ment of prognostic models were collected: modeling
methods [e.g. logistic regression, by consensus, or classi-
fication and regression tree (CART) models], handling
of continuous predictors and missing values, method of
predictor selection, model presentation (e.g. nomogram,
score chart, or formula with regression coefficients), model
validation (e.g. internal and external validation), measures
of calibration and discriminative ability (e.g. c-indices),
classification measures (e.g. specificity and sensitivity, and
positive and negative predictive values).
The original equations or score charts were used to
conduct quantitative external validation in order to as-
sess the measures of calibration and discriminative abil-
ity of the retrieved models using the empirical data at
hand. The original investigators of the eligible prediction
models were contacted if the manuscript did not present
the intercept and predictor-outcome associations of the
regression equation.
Risk of bias assessment
In contrast to reviews of randomised therapeutic studies
and diagnostic test accuracy studies, a formal guideline
for critical appraisal of studies reporting on clinical pre-
diction models does not yet exist. However, we assessed
the quality of the included prediction models, assem-
bling criteria based on two sources. First, we assembled
quality criteria as published in reviews on prognostic
studies [16,17]. Second, as prediction models usually
come from observational studies, we used the Strength-
ening the Reporting of Observational Studies in Epi-
demiology (STROBE) [18]. This initiative developed
recommendations on what should be included in an ac-
curate and complete report of an observational study,
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abstract, introduction, methods, results, and discussion
sections of articles. The methodological quality of the
studies that developed prediction models using an obser-
vational cohort was assessed using the STROBE state-
ment. The presence or absence of report characteristics
was independently assessed by two reviewers (WO and
MO). Furthermore, as recommended, the statistical
methods, missing data reporting, and use of sensitivity
analyses were judged. From the information in the Re-
sults and Discussion sections of each report the inclu-
sion and attrition of patients at each stage of the study,
reporting of baseline characteristics, reporting of the
study’s limitations, the generalizability, and whether the
source of funding was reported, were assessed and
judged. High risk of bias was considered present when
no descriptions of patient selection or setting, or no de-
scription of outcomes, predictors, or effect modifiers
were found in the report. Unclear risk of bias was con-
sidered present when these items were described, but in
an unclear manner. Otherwise low risk of bias was
concluded.
Quantifying the predictive accuracy of the retrieved
models in a large independent dataset
The Prevention of Ventilator Induced Lung Injury Col-
laborative Group (PreVILIG collaboration) was formed
in 2006 with the primary investigators of all RCTs com-
paring elective high frequency ventilation (HFV) with
conventional ventilation in preterm infants with respira-
tory failure in order to investigate the effect of these
ventilation strategies using individual patient data [19].
Access to and management of the individual patient data
from the PreVILIG database has been described in the
published protocol [20]. PreVILIG collaborators pro-
vided de-identified individual patient data to the PreVI-
LIG Data Management Team. Access to the PreVILIG
dataset was restricted to members of the PreVILIG
Steering Group and Data Management Team. The ori-
ginal investigators continued to have control over how
their data were analyzed. Newly planned analyses, such
as reported in this paper, were only done if collaborators
were fully informed and agreed with them.
The need for review by an ethical board has been
waived. However, collaborators providing individual pa-
tient data, signed a declaration that under no circum-
stance patient information could possibly be linked to
the patient identity.
From the 17 eligible RCTs on this topic in the litera-
ture, 10 trials provided pre-specified raw data from each
individual study participant, including patients’ charac-
teristics, ventilation parameters, early blood gas values
and neonatal outcomes. These data from 3229 patients,
born between 1986 and 2004, were stored in a centraldatabase. The mean gestational age of these infants was
27.3 weeks (standard deviation (SD) ±3.8 weeks) and
mean birth weight was 989 grams (SD ±315 grams). Ex-
ternal validation of the retrieved models was performed
using the PreVILIG database after agreement by all the
PreVILIG collaborators.
In this dataset, patient characteristics such as gesta-
tional age, birth weight, gender, Apgar score at 5 minutes
and antenatal steroids were available for all infants. The
median age at randomization varied between 0.3 and
13.5 hours after birth. Information on mean airway pres-
sure (Paw) and the fractional inspired oxygen concentra-
tion (FiO2) were provided for the first 24 hours and data
on ventilator settings during the first 72 hours after
randomization. Data on the arterial partial oxygen ten-
sion (PaO2) were collected on randomization, whereas
partial carbon dioxide tension (PaCO2) values (arterial
or capillary) were available for the first 72 hours after
randomization. Clinical data on surfactant use, postnatal
age at randomization, and age at extubation; morbidities
such as persistent ductus arteriosus, pneumothorax, pul-
monary interstitial emphysema and intracranial hemor-
rhage; and death at 36 weeks PMA as well as the
incidence of BPD defined as oxygen dependency at
36 weeks PMA were also collected. In general, the per-
centage of missing information from the individual patient
data was low, less than 10%.
Most prediction models used conventional respiratory
support in their developmental cohorts and therefore in-
cluded solely conventional respiratory settings as pre-
dictor variables. The external PreVILIG cohort included
infants on HFV and on conventional ventilation [19]. No
apparent difference was seen in the outcome estimate
BPD or the combined outcome death or BPD in the in-
dividual patient data (IPD) analysis by Cools et al. [19].
Therefore, the IPD of both intervention arms (HFV and
conventional ventilation) were included in the analyses
in the calculation of the prediction model. For models
including predictors of conventional ventilation, only the
patients in the IPD assigned to the conventional arm
could be used. We assessed the discriminative perform-
ance of the included models using data of infants who
were randomized to the conventional ventilation arm in
a separate analysis and compared the results with the
analysis of data from all infants.
Statistical analyses
The included prediction models were validated using the
reported information (i.e. regression coefficients, score
charts or nomograms) by matching the predictors in
each model to the variables in the PreVILIG dataset. A
direct match was available in the PreVILIG dataset for
most variables. When a predictor was not available in
PreVILIG, we sought to replace the variable with a proxy
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domly substituted (e.g. imputed) the mean value re-
ported in the literature for these predictors [21]. To
prevent over-imputation this procedure was only per-
formed when the missing predictor from the model had
a low weight in the equation compared to the other pre-
dictors. If none of these methods could be applied, the
clinical prediction model had to be excluded and was
not tested in the external cohort.
Using these methods, we calculated the probability of
developing BPD at 36 weeks PMA and the combined
outcome death and BPD at 36 weeks PMA for each indi-
vidual patient in the PreVILIG dataset. Although not all
retrieved models were developed to predict both out-
comes, the performance of all models was evaluated for
both outcomes in terms of their discrimination and
calibration.
First, the discriminative performance of the prediction
models was quantified by constructing receiver operat-
ing characteristic (ROC) curves and calculating the cor-
responding area under the curves (AUC) with a 95%
confidence interval. The ROC curve is commonly used
for quantifying the diagnostic value of a test to discrim-
inate between patients with and without the outcome
over the entire range of possible cutoffs. The area under
the ROC curve can be interpreted as the probability that
a patient with the outcome has a higher probability of
the outcome than a randomly chosen patient without
the outcome [17].
Second, the calibration of all models was assessed.
This describes the extent of agreement between the pre-
dicted probability of BPD (or the combined outcome
death or BPD) and the observed frequency of these out-
comes in defined predicted risk strata. Model calibration
was visually assessed by constructing calibration plots
and evaluating agreement between predicted and ob-
served probabilities over the whole range of predictions
[17]. As the calibration of a predictive model in an inde-
pendent data set (external validation set) is commonly
influenced by the frequency of the outcome in the valid-
ation set, we adjusted the intercept of each model using
an offset variable in the validation data to account for
prevalence differences between the populations before
applying it to the data, such that the mean predicted
probability was equal to the observed outcome fre-
quency [22]. Calibration plots were constructed for the
top 5 discriminating prediction models [23].
In order to determine the impact of the missing values
within the PreVILIG database on the performance and
accuracy of the prediction models, missing data were
imputed by means of multiple imputation using “Multi-
variate Imputation by Chained Equations” (MICE) [24].
This procedure is an established method for handling
missing values in order to reduce bias and increasestatistical power [21]. Missing values were imputed 10
times for each separate trial, or, when variables were
completely missing within a trial the median observed
value over all trials was used. Estimates from the result-
ing 10 validation datasets were combined with Rubin's
rule (for calculating AUCs) and with averaging of model
predictions (for constructing calibration plots) [25]. Sen-
sitivity analyses were performed to compare accuracy
and calibration in validations with and without these im-
puted values.
All AUCs and calibration plots were constructed using
R statistics (R Development Core Team (2011). R: A lan-
guage and environment for statistical computing. R
Foundation for Statistical Computing, Vienna, Austria).
All statistical tests were conducted two-sided and con-
sidered statistically significant when p < 0.05.
Results
Literature search
The search strategy identified 48 relevant reports (46
found on MEDLINE and 2 by hand search of the Annual
Scientific Meetings, see Figure 1). Electronic searches of
EMBASE, CINAHL and the CENTRAL in the Cochrane
Library revealed no new relevant studies. The abstracts
of these studies were reviewed independently by two re-
viewers (WO and MM) for inclusion in this project.
After reading the full papers, 22 reports were excluded
from this review for the reasons shown in Figure 1. Thir-
teen of the 22 excluded articles did not present a genu-
ine prediction model, but were observational studies on
risk factors for the outcome BPD.
Compared to the search query developed for the iden-
tification of prediction models in non-pediatric medicine
[15], the present search strategy yielded a higher com-
bination sensitivity and specificity by identifying 5 eli-
gible prediction models without missing a citation, but
at the expense of a higher number needed to read (NNR
93.2 vs. 74.4).
Finally, 26 study reports with publication dates ranging
from 1983 to 2011 could be included in this review.
Eighteen studies developed a multivariable prediction
model [12-14,26-40], whereas four reported the per-
formance of univariable parameters as a prediction
model [41-44]. The remaining 4 reports [45-48] were
studies validating existing prediction models originally
designed for other outcomes, such as mortality [49-51].
Although developed for another outcome, these valid-
ation studies aimed to determine to which extent the
prediction rule could predict BPD. Of the included re-
ports, four studies developed a model using radiographic
scoring, but also a prediction rule without this diagnos-
tic tool and were therefore included [13,26,29,44]. Four
study reports presented a prediction rule based on clin-
ical information collected after the 7th postnatal day
Systematic Review
1958 Potentially relevant citations screened for retrieval
1934 Identified by Pubmed search
24 Identified by search of meeting abstracts and other sources
1814 Citations excluded (clearly not relevant)
144 Abstracts retrieved for more detailed evaluation
120 From Pubmed search
24 From meeting abstracts and other sources
96 Abstracts excluded
12 Using pulmonary mechanic, radiographic, serum, tracheal parameters
4 Time related or demographic cohort studies
6 Prediction neurologic development 
13 Prediction model > 7 days PNA
59 No prediction model, but risk factors BPD or other outcomes
1 Double publication of included manuscript
48 Full-text reports or meeting abstracts retrieved 
for detailed information
22 manuscripts excluded
13 No prediction model 
2 Outcome mortality or morbidity > 36 wks PMA
1 Combined outcome survival without major morbidity
3 Models using only radiographic/lung function parameters 
3 Full manuscripts not retrievable 
26 included prediction models (1 hand searched)
18 derivation studies [12-14,26-40]
8 validation studies [41-48]
19 prediction models 
validated with PreVILIG 
[14,26,29-34,36,37,39-46,48]
6 prediction models 
variables not available in 
PreVILIG [12,13,28,35,38,47]
1 prediction model 
equation not available [27]
Systematic Review
External Validation
Figure 1 Flowchart of the systematic review of prediction models for BPD in preterm infants (updated on 01-04-2012) and the
possibility of external validation using the PreVILIG dataset.
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sented a prediction rule based on early postnatal infor-
mation as well, which was included [14,30,34,40].
Characteristics of prediction models
The models’ characteristics (Table 1) are presented for
derivation studies (i.e. studies developing a novel predic-
tion model) and validation studies (i.e. studies evaluating
a single predictor or a known model for outcomes other
than BPD). All models show much heterogeneity with
respect to the years the data were collected, study de-
sign, total numbers of patients and gestational age. Nine
of the derivation cohorts included non-ventilated pa-
tients in their developmental cohort (50%). Most studies
were based on collection of data in a single-center set-
ting. The earlier prediction models calculated theirmodels on the outcome BPD at 28 days of postnatal age,
whereas after the millennium all studies aimed for the
diagnosis of BPD at the 36th week PMA. Two models
defined BPD according to recently established inter-
national criteria [52,53]. These models used the physio-
logical definition at 36 weeks PMA and divided BPD
into grades of severity [39,40].
Overview of considered and selected predictors
Candidate predictors differed substantially across the
identified derivation studies (Table 2), and after variable
selection a median of 5 included predictors was found
(range 2–12). A large proportion of the models used the
infants’ gestational age and/or birth weight to calculate
the risk for BPD (18 and 16 models, respectively). Gen-
der and low Apgar scores were included in only 5 and 8
Table 1 Characteristics of prediction models
Study Year of
publication
Region
(No. Of Centers)
Period of
data
collection
Study
design†
Non-ventilated
patients
included
No. of patients
derivation
cohort
ROC
timing
Gestational age
(wks, mean ± SD)
Original
outcome
Internal/
External
validation
No. of patients
validation
cohort‡
Derivation cohorts
Cohen [12] 1983 USA (1) 1987-1981 Pros No - 2d Un§ Death/BPD 30d Yes/No 69/-
Hakulinen [13] 1988 Finland (1) 1978-1982 Pros Yes 91 1d Un§ Death/BPD 28d No/No −/−
Sinkin [14] 1990 USA (3) 1983-1985 Retro Yes 160 12 h 30.9 (±4.2) BPD 28d Yes/Yes 49/189
Palta [26] 1990 USA (5) - Retro Yes - 3d Un§ BPD 30d Yes/No 42/-
Parker [27] 1992 USA (1) 1976-1990 Retro Yes 2375 at adm. Un§ Death/BPD 28d Yes/No Un§/-
Corcoran [28] 1993 UK (1) 1980-1990 Retro No 312 3d Un§ BPD 28d Yes/No 100/-
Ryan 1994 [29] 1994 UK (2) 1988-1989 Retro No 166 7d 28 (23–31)£ BPD 28d No/Yes -/133
Rozycki [30] 1996 USA (1) 1987-1991 Retro No 698 8 h Un§ BPD 28d No/No −/−
Ryan 1996 [31] 1996 UK (1) 1991-1992 Retro No 202 4d 28 (23–27)£ BPD 36w Yes/No 47/-
Romagnoli [32] 1998 Italy (1) 1989-1991 Retro No 50 3d, 5d 28.4 (±2.2) BPD 28d Yes/No 149/-
Yoder [33] 1999 USA (3) 1990-1992 Pros Yes 107 12 h, 72 h Un§ Death/BPD 36w Yes/Yes 54/56
Kim [34] 2005 Korea (1) 1997-1999 Retro Yes 197 4d, 7d 28.2 (±1.9) BPD 36w Yes/No 107/-
Cunha [35] 2005 Brasil (1) 2000-2002 Pros No 86 7d 27.2 (±3.2) BPD 36w No/No −/−
Choi [36] 2006 Korea (Un§) - - No 81 1d, 4d, 7d Un§ BPD 36w No/No −/−
Henderson-Smart [37] 2006 Aus/NZ (25) 1998-1999 Pros Yes 5599 at birth 29 (27–30)£ BPD 36w Yes/No 5854/-
Bhering [38] 2007 Brasil (1) 1998-2003 Retro Yes 247 7d 29.1 (±2.4) BPD 36w Yes/No 61/-
Ambalavanan [39] 2008 USA (16) 2001-2003 Pros No 420 variable 26 (±2) Death/BPD 36w No/No −/−
Laughon [40] 2011 USA (17) 2000-2004 Pros Yes 2415 1d, 3d, 7d 26.7 (±1.9) Death/BPD 36w Yes/Yes 1214/1777
Validation cohorts
Subhedar [41] 2000 UK (1) - Retro No NA <24 h 29 (26–30)£ Death/BPD 36w - NA/155
Srisuparp [42] 2003 USA (1) 1996-1997 Retro No NA <6 h 27.6 (±2.4) BPD 36w - NA/138
Choukroun [43] 2003 France (1) - Retro No NA at SF/18 h after 29.5 (±1.5) BPD 36w - NA/44
Greenough [44] 2004 UK (1) 1998-2001 Retro No NA 7d 26 (24–28.6)£ Death/BPD 36w - NA/59
Fowlie [45] 1998 UK (6) 1988-1990 Retro Yes NA 72 h 29 (23–38)£ Death/BPD 36w - NA/398
Hentschel [46] 1998 Germany (1) 1991-1993 Retro Yes NA at adm. 28.6 (±0.3) Death/BPD 36w - NA/188
Chien [47] 2002 Canada (17) 1996-1997 Pros Yes NA at adm. 29 (±2) BPD 36w - NA/4226
May [48] 2007 UK (1) 2004-2005 Retro Yes NA 2d Un§ BPD 28d/36w - NA/75
† Pros: prospective; retro: retrospective ‡ Number of patients in validation cohort: internal/external. §Un Unknown. ¶ Manuscripts validating the outcome BPD on models originally derived for different outcomes
(e.g. mortality). £ Median gestational age (range). NA Not applicable.
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Table 2 Overview of selected and used predictors in models
Study Cohen
[12]
Hakulinen
[13]
Sinkin
[14]
Palta
[26]
Parker
[27]
Corcoran
[28]
Ryan
1994
[29]
Rozycki
[30]
Ryan
1996
[31]
Romagnoli
[32]
Yoder
[33]
Kim
[34]
Cuhna
[35]
Choi
[36]
Henderson-
Smart [37]
Bhering
[38]
Amblavanan
[39]
Laughon
[40]
Subhedar
[41]
Srisuparp
[42]
Choukroun
[43]
Greenough
[44]
Fowlie
[45]
Hentschel
[46]
Chein
[47]
May
[48]
Total %
(n = 26)
Total number
of predictors
considered
NA 19 79 NA 14 16 9 16 10 Un 7 27 20 Un 21 66 26 15 NA 19 NA NA 41 5 12 NA
Total number
of predictors
selected
2 5 4 8 7 8 4 5 3 3 6 8 4 3 3 4 6 6 NA 2 NA NA 6 5 12 NA
Selected
predictors
Clinical
Gestational age x x x x x x x x x x x x x x x x x x 69 (18)
Birth weight x x x x X x x x x x x x x x x x 62 (16)
Small for
gestational age
x 4 (1)
Race/ethnicity x x 8 (2)
>15 % Birth
weight loss
x 4 (1)
Gender x x x x x x 23 (6)
Antenatal
steroids
x 4 (1)
Outborn x x x 12 (3)
Apgar score x x x x x x x x 31 (8)
Surfactant use x x x 12 (3)
Patent ductus
arteriosus
x x x x 15 (4)
Fluid intake
day 7
x 4 (1)
Lowest blood
pressure
x 4 (1)
Lowest
temperature
x 4 (1)
Urine output x 4 (1)
Respiratory
distress
syndrome
(RDS)
x x x 12 (3)
Severity of RDS x 4 (1)
Pneumonia x x x 12 (3)
Pulmonary
hemorrhage
x 4 (1)
Pulmonary
interstitial
emphysema
x x x 12 (3)
Sepsis x 4 (1)
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Table 2 Overview of selected and used predictors in models (Continued)
Seizures x x 8 (2)
Intraventricular
hemorrhage >
grade II
x x 8 (2)
Congenital
malformation
x 4 (1)
Postnatal age
at mechanical
ventilation
x 4 (1)
Ventilator
settings
Modality x x x x 15 (4)
Mean FiO2 x x x x x x 23 (6)
Minimum FiO2 x 4 (1)
Maximum FiO2 x x x x x x 23 (6)
Duration FiO2
> 0.6
x x 8 (2)
FiO2 1.0 for >
24 hr
x 4 (1)
Positive
inspiratory
pressure (PIP)
x x X x x x 23 (6)
Duration PIP >
25cmH2O
x 4 (1)
Rate x x 8 (2)
Intermittent
mandatory
ventilation
(IMV)
x X x x 15 (4)
IMV > 24 hrs or
> 2d
x x x 8 (2)
Mean airway
pressure
x x x 12 (3)
Ventilator
index
x 4 (1)
Laboratory
pH x 4 (1)
pO2 x x 8 (2)
Oxygenation
index
x x x x x 19 (5)
A-a DO2 x x 8 (2)
Pa/AO2 x x 8 (2)
Base excess x x 8 (2)
NA Not applicable; Un Unknown.
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bivariable model used some form of the ventilator set-
tings variable as a predictor, except for the one devel-
oped by Henderson-Smart, which only used birth
weight, gestational age and gender in the equation [37].
Most models selected either the amount of oxygen ad-
ministered, or the positive inspiratory pressure or mean
airway pressure. A minority of the models used blood
gasses at an early age as a predictor for BPD.
Quality and methodological characteristics model
derivation
The methodological quality of derivation studies was
generally poor (Table 3). Most studies used logistic re-
gression analysis during model development. However,
two studies did not employ a statistical approach and
solely relied on expert opinion and consensus [12,26].
Apparent model quality was mainly degraded by catego-
rization of continuous predictors (about 58% of the pre-
diction models), employing unclear or naïve approaches
to deal with missing values (84% of the studies did not
address this issue at all), and using obsolete variable se-
lection techniques (5 models used univariable P-values).
Derived prediction models were mainly presented as an
equation (11 studies). Score charts (5 studies) and no-
mograms (2 studies) were less common.
Ten of the 19 models were only internally validated
using cross-validation. This was usually achieved with a
low number of included patients, except for two multi-
center studies [37,40]. External validation was performed
in 4 studies [14,29,33,40]. The discriminative perform-
ance of the different models was evaluated by calculating
the AUC, or evaluating ROC curves or sensitivity and
specificity. The reporting of calibration performance in
all multivariable, bivariable and univariable prediction
models was completely neglected.
The reporting quality of the observational studies is
shown in Figure 2. There was a high correlation between
the two independent assessors with only 2.7% initial dis-
agreement (17 of of 624 scored items). These disagree-
ments were resolved after discussion and consensus was
reached.
The overall quality of the included studies was judged
“high risk of bias”, “unclear risk of bias” or “low risk of
bias” for all 22 items of the STROBE instrument. The in-
dividual items that were judged as high risk of bias in-
cluded: lack of reporting possible sources of bias in the
Methods section; not reporting actual numbers of pa-
tients in the different stages of the study; failing to re-
port analyses of subgroups; not addressing interactions
or doing sensitivity analyses. Few studies addressed their
limitations and the generalizability of their results. Fur-
thermore, nearly 50% of the studies did not report their
funding source.External validation of the eligible models
We were able to perform external validation with the
PreVILIG dataset in 19 of the 26 eligible prediction
models. One study did not present the actual formula of
the derived prediction model. The original investigators
were not able to provide these data, and therefore its
validation was not possible [27]. Two authors provided
estimated predictor-outcome associations that were not
described in the original reports [39,40]. One author
agreed to re-analyze their data in order to construct sep-
arate models for predicting the combined outcome of
death and BPD [40].
Six models could not be validated because variables on
either fluid intake, weight loss after the first week of life,
or exact duration of high oxygen and positive inspiratory
pressure were not available in the PreVILIG dataset and
no proxy variable could be imputed [12,13,28,35,38,47].
One study presented three models: a score chart, a di-
chotomized predictor and a model keeping all continu-
ous variables linear [54]; the latter of these models was
validated with the PreVILIG dataset [32]
The method of replacing a missing variable by a proxy
was used in 3 prediction models [40,45,46]. The “base
excess” values were imputed according to the mean
values found in the literature [55,56]. Because subject
ethnicities were not recorded in the PreVILIG validation
dataset, imputation was applied on a per-trial level ac-
cording to reported percentages of ethnicity. If this in-
formation was not available, the local percentage was
imputed. For one model, the variable “pulmonary
hemorrhage” was removed from the equation, since in
the literature a negligible frequency of this complication
was found, confirmed both by clinical experience and
the low frequency in the original developmental cohort
of this model itself [26].
Discriminative performance
The discriminative performance of the models validated
with the PreVILIG dataset (Table 4) in the complete case
analyses (CCA) and multiple imputation analyses (MI)
ranged from 0.50 to 0.76 for both outcomes. Regarding
the outcome BPD, superior discrimination was achieved
for multivariable models, with AUC values above 0.70
(CCA). The model derived by Ryan et al. in 1996 achieved
the best discrimination [AUC 0.76; 95% confidence inter-
val (CI) 0.73, 0.79], and their previous model reported in
1994 performed similarly [29,31]. Also the model of Kim
et al. showed fair discrimination. These models calculate
the prediction on the 7th (Ryan 1994) and 4th (Ryan 1996,
Kim) day after birth, a relatively late stage [29,34]. Only
two models that had an AUC above 0.70 in the CCA used
predictors assessable on the first day of life [14,26].
Five models with the best discriminating performance
for BPD showed an AUC of more than 0.70 for the
Table 3 Methodological characteristics of derivation studies
Model development Cohen
[12]
Hakulinen
[13]
Sinkin
[14]
Palta
[26]
Parker
[27]
Corcoran
[28]
Ryan
1994
[29]
Rozycki
[30]
Ryan
1996
[31]
Romagnoli
[32]
Yoder
[33]
Kim
[34]
Cuhna
[35]
Choi
[36]
He rson-
Sm [37]
Bhering
[38]
Ambalavanan
[39]
Laughon
[40]
Total %
(n = 19) *
Type of model
Regression analysis x x x x x x x x X x x x x x x 84 (16)
Tree/recursive partitioning x 5 (1)
Other x x 11 (2)
Preliminary data analysis
Handling of continuous predictors
Kept linear x x x x x x x† 41 (7)
Categorized x x X x x 35 (6)
Dichotomized x x# x x x 29 (5)
Missing values
Complete case study x x x 21 (4)
Imputations x x 11 (2)
Not specified x x x x x x X x x x x x 63 (12)
Selection
Stepwise selection x x x x X x x x x x 53 (10)
Univariate P-values x x x x 26 (5)
No selection x x x 16 (3)
Presentation
Score chart x x x x x x 26 (5)
Nomogram x x 11 (2)
Model formula x x x x x x x x x x 58 (11)
Model validation
Internal
Cross-validation x x x x x x x x x 53 (10)
Bootstrapping x 5 (1)
Split sample x x 11 (2)
External
New data set x x x x 21 (4)
Calibration measures
Calibration Goodness of fit x 11 (2)
Calibration plot 0 (0)
Calibration intercept and slope 0 (0)
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Table 3 Methodological characteristics of derivation studies (Continued)
Discrimination measures
ROC/area under ROC x x x x x x x x 42 (8)
Classification
Sensitivity/specificity x x x x x x x x x x 53 (10)
Accuracy rate x x 11 (2)
other x x x 16 (3)
* Two models [12,13] did not include continuous estimators in their models, so handling of continuous predictor are calculated over 17 models.
# Romagnoli [32] presented 3 models, of which one dichotomized birth weight and one score chart.
† Ambalavanan [39] presented a CART model dichotomizing continuous predictor estimates in his manuscript, but provided us a model formula keeping the continuous outcomes linear.
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Figure 2 Methodological quality of the observational cohorts according to the STROBE instrument. Per item in the STROBE instrument,
the red colour represents high risk of bias (“No”), the blue colour represents unclear risk of bias (“Unclear”), and the green colour represents low
risk of bias (“Yes”).
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http://www.biomedcentral.com/1471-2431/13/207combined outcome death or BPD at 36 weeks PMA
[14,26,31,34,40], together with two models with a lower
discriminating performance on the outcome BPD
[33,46].
In contrast with predicting the outcome BPD, external
validation of the univariable variables gestational age
and birth weight showed an AUC ≥ 0.70 when calculated
for the combined outcome death and BPD at 36 weeks
PMA, underlining the weight of these two variables for
the prediction of that outcome.
The range of number of patients with data on the re-
quired variables available in the PreVILIG dataset for the
different models varied widely from 322 to 2429 pa-
tients. This may explain why validation results from
CCA and MI sometimes considerably differed. However,
multiple imputation generally resulted in a decreased
AUC and these differences did not exceed 10% of the
original score (Table 4). The model derived by Laughon
et al. achieved the highest AUC for both outcomes, with
CCA and MI [40].
The separate validation analysis of the models using
only the conventionally ventilated infants in the PreVI-
LIG dataset did not change the discriminative perform-
ance of the models under consideration, although their
confidence intervals increased due to loss of power (data
not shown).
Calibration
The calibration was assessed for the 5 best-discriminating
models on both the outcome BPD at 36 weeks PMA
and the combined outcome death or BPD at 36 weeksPMA (CCA and MI) [14,26,31,34,40]. These plots are
presented after adjustment of the intercept of each
model in the validation data (Figures 3, 4, 5, 6 and 7) re-
spectively displaying the outcome BPD (A) and the com-
bined outcome death or BPD at 36 weeks (B)). The
dashed line represents the ideal calibration (with inter-
cept 0 and regression coefficient 1). The dotted line rep-
resents the calibration performed with complete case
analysis (CCA), whereas the dash-dot line represents the
multiple imputation analyses (MI). Because the incidence
of BPD in the PreVILIG dataset differed from the ori-
ginal derivation cohorts, the calibration plots are pre-
sented with an adjusted intercept. The calibration line
does not correspond well with the reference line (i.e. the
predicted outcomes do not agree with the observed fre-
quencies in all risk strata) in three of the five plots,
showing both over- and underestimation by the models
over the entire range of predicted probabilities (Figures 3,
4, 5, 6 and 7) [17]. The models showing good calibration
are the models derived by Ryan and Laughon (Figures 6
and 7) [31,40].
Discussion
We present the first systematic review identifying, ap-
praising and externally validating all previously pub-
lished prediction models on BPD in premature infants.
We identified 26 studies published over 30 years. The
external validation of 19 prediction models in the large
independent PreVILIG dataset showed a broad range of
discrimination performance from poor to fair. Further-
more, even with fair discriminative performance, only
Table 4 Areas under the ROC curve of the different prediction models
Original cohort PreVILIG cohort
Study Derivation Internal BPD at 36 wks PMA Combined Death or BPD
CCA MI CCA MI
AUC AUC N AUC (95 % CI) AUC (95 % CI) N AUC (95 % CI) AUC (95 % CI)
Multivariate models
Sinkin [14] - - 829 0.70 (0.67, 0.74) 0.68 (0.66, 0.70) 997 0.75 (0.72, 0.78) 0.74 (0.72, 0.76)
Palta [26] - - 346 0.73 (0.67, 0.78) 0.70 (0.68, 0.72) 401 0.74 (0.69, 0.79) 0.75 (0.73, 0.77)
Ryan 1994 [29] 0.91 0.94 2030 0.72 (0.70, 0.74) 0.66 (0.64, 0.68) 2393 0.69 (0.67, 0.71) 0.67 (0.65, 0.69)
Rozycki [30] - - 2429 0.54 (0.53, 0.56) 0.52 (0.50, 0.54) 2888 0.54 (0.53, 0.55) 0.55 (0.53, 0.57)
Ryan 1996 [31] 0.85 0.97 1010 0.76 (0.73, 0.79) 0.70 (0.68, 0.72) 1171 0.76 (0.73, 0.78) 0.73 (0.71, 0.75)
Romagnoli [32] 0.97 0.96 390 0.60 (0.55, 0.66) 0.62 (0.60, 0.65) 449 0.61 (0.56, 0.66) 0.65 (0.63, 0.67)
Yoder [33] - - 330 0.67 (0.61, 0.73) 0.68 (0.66, 0.70) 380 0.72 (0.67, 0,77) 0.73 (0.71, 0.75)
Kim [34] 0.76 0.90 322 0.71 (0.65, 0.77) 0.68 (0.66,0.70) 366 0.75 (0.70, 0.80) 0.73 (0.71, 0.75)
Choi [36] - - 913 0.60 (0.56, 0.64) 0.66 (0.64, 0.68) 1050 0.69 (0.66, 0,72) 0.71 (0.69, 0.73)
Henderson-Smart [37] 0.84 0.84 2128 0.65 (0.62, 0.67) 0.64 (0.62, 0.66) 2585 0.69 (0.67, 0.71) 0.69 (0.67, 0.71)
Ambalavanan [39] - - 795 0.61 (0.57, 0.65) 0.65 (0.63, 0.67) 891 0.66 (0.62, 0.70) 0.69 (0.67, 0.71)
Laughon [40] 0.81 0.81 801 0.70 (0.67, 0.74) 0.71 (0.69. 0.73) 960 0.74 (0.70, 0.77) 0.74 (0.72, 0.76)
Fowlie [45] NA NA 1006 0.64 (0.60, 0.67) 0.65 (0.63, 0.68) 1166 0.69 (0.66, 0.72) 0.69 (0.67, 0.71)
Hentschel [46] NA NA 1885 0.66 (0.64, 0.69) 0.65 (0.63, 0.67) 2256 0.71 (0.69, 0.73) 0.70 (0.68, 0.72)
Bivariate models External
May [48] NA 0.76 1918 0.55 (0.52, 0.58) 0.54 (0.52, 0.56) 2262 0.60 (0.58, 0.63) 0.58 (0.56, 0.60)
Univariate models
Oxygenation index
Srisuparp [42] NA 0.65 896 0.50 (0.46, 0.54) 0.54 (0.51, 0.56) 1029 0.53 (0.50, 0.57) 0.52 (0.52, 0.57)
Greenough [44] NA 0.72
Gestational age
Subhedar [41] NA 0.81 2428 0.65 (0.63, 0.68) 0.64 (0.61, 0.66) 2885 0.70 (0.68, 0.72) 0.67 (0.67, 0.70)
Choukroun [43] NA 0.73
Greenough [44] NA 0.42
Birth weight
Subhedar [41] NA 0.82 2429 0.69 (0.66, 0.71) 0.67 (0.65, 0.69) 2888 0.73 (0.71, 0.75) 0.69 (0.69, 0.73)
Choukroun [43] NA 0.73
Greenough [44] NA 0.54
Maximum FiO2 NA 0.66 2126 0.54 (0.52, 0.57) 0.55 (0.53, 0.57) 2511 0.60 (0.57, 0.62) 0.56 (0.56, 0.60)
Antenatal steroids NA 0.54 2347 0.53 (0.51, 0.55) 0.52 (0.50, 0.54) 2800 0.50 (0.48, 0.52) 0.50 (0.48, 0.52)
Surfactant NA 0.77 2429 0.55 (0.53, 0.57) 0.52 (0.51, 0.54) 2888 0.53 (0.52, 0.55) 0.53 (0.51, 0.54)
Ventilation > 7 days NA 0.75 2190 0.64 (0.62, 0.66) 0.59 (0.58, 0.61) 2556 0.58 (0.57, 0.60) 0.58 (0.56, 0.59)
CCA Complete case analysis; MI Multiple imputation analyses; AUC Area under the curve of the receiver operator characteristics; CI Confidence interval;
NA Not applicable.
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http://www.biomedcentral.com/1471-2431/13/207two models showed good calibration [31,40]. The imple-
mentation of these models in daily clinical and research
practice was previously jeopardized by several limitations.
First, identified prediction models were rarely exter-
nally validated, but were predominantly evaluated by
some type of internal validation. The few external valid-
ation studies done were performed in small datasets,rendering published results highly susceptible to sam-
pling variability. Furthermore, almost all studies ex-
cluded the cases with missing values or did not specify
how these cases were handled during validation [21]. As
a consequence, most identified prediction models had an
unclear generalizability [10]. Our multiple imputation
analyses showed that only three models reached an AUC
A B
Figure 3 Calibration plot of prediction model as described by Sinkin [14] for the outcome BPD (panel A) and the combined outcome
death or BPD at 36 weeks (panel B).
BA
Figure 4 Calibration plot of prediction models as described by Palta [26] for the outcome BPD (panel A) and the combined outcome
death or BPD at 36 weeks (panel B).
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B A 
Figure 5 Calibration plot of prediction model as described by Kim [34] for the outcome BPD (panel A) and the combined outcome
death or BPD at 36 weeks (panel B).
BA
Figure 6 Calibration plot of prediction model as described by Ryan 1996 [31] for the outcome BPD (panel A) and the combined
outcome death or BPD at 36 weeks (panel B).
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A B
Figure 7 Calibration plot of prediction models as decribed by Laughon [40] for the outcome BPD (panel A) and the combined outcome
death or BPD at 36 weeks (panel B).
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that is considered ‘fair’ in the literature [26,31,40], and
seven models on the combined outcome death or BPD at
36 weeks PMA reached this value [14,26,31,33,34,36,40,46].
It is now widely accepted that if the value of the discrimin-
ant performance expressed in AUC ROC is less than 0.80,
the model should be used with caution [57].
Second, no prediction model previously evaluated or
reported its calibration. Our study demonstrates that
even for models with a fair discriminative performance,
calibration was far from ideal. Particularly, three of the
five best discriminant models showed both over- and
underestimation over the entire range of BPD probabilities
[14,26,34]. One model with good calibration has a limited
usefulness because it only estimates the BPD risk on the
4th day of life and does not account for other forms of
mechanical ventilation [31]. Another model with good
calibration could not be fully evaluated because one of its
predictors, HFV vs. conventional ventilation, was a ran-
domized variable in the PreVILIG dataset [40].
Third and most importantly, none of the identified pre-
diction models had undergone a proper implementation
phase in clinical practice and research. An impact analysis
is needed to quantify whether the use of the prognostic
model does improve decisions and treatment and, more
importantly, does improve patient outcome [11].
In summary, we conclude that although the prediction
models have a reasonable quality of reporting, there aremany gaps in the development, validation and impact
stages of the presented models. The external validation
study shows that most prediction models do not per-
form well enough to be considered in routine care. Out
of 19 validated models, only 2 showed promising dis-
crimination and calibration [31,40].
Several lessons can be learned from the results of this
extensive validation study. In line with previous research,
univariable models yield a lower discriminative ability
than multivariable models. The best discriminating
models selected either gestational age, birth weight, or
both as a predictor. These predictors are established risk
factors for BPD [52,58]. All models used respiratory/
mechanical ventilator settings as predictors, for example
the concentration of supplemental oxygen or the inspira-
tory pressure applied to the infant. Finally, this system-
atic review can guide researchers in developing or
updating existing prediction models following the meth-
odology described above.
Limitations
To fully appraise the results of our systematic review, a
few important limitations need to be considered. First,
of the 26 eligible models, only 19 could be validated in
the PreVILIG dataset. Although it is possible that the
remaining models have good performance, this remains
untested so far, as some predictor variables were unavail-
able in the PreVILIG study. However, these variables
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ardizing their implementation in routine care. For in-
stance, three of the untested models included the
concentration of oxygen or positive inspiratory pressure
for a prescribed time [12,13,28], or included weight loss,
fluid intake or urine output as predictors [35,38,47].
These variables are not collected easily even in a pro-
spective study and more importantly are not independ-
ent of local protocols or habits [12,28].
Second, a limitation of the validation using the PreVI-
LIG dataset is that this dataset only contains ventilated
preterm infants and their available parameters during
the first days of life. Today more and more infants are
initially managed without invasive ventilation. Although
these preterm infants often have decreased need for sup-
plemental oxygen or mechanical ventilation in the first
postnatal week, many infants have a pulmonary deterior-
ation in the second postnatal week, with an increased
need for supplemental oxygen and respiratory support,
and many will eventually develop BPD [59]. Ideally, the
identified prediction models should be validated using a
dataset of both ventilated and non-ventilated preterm in-
fants from a recently collected multicenter cohort, defin-
ing the outcome BPD according to recent established
criteria that include the severity of the diagnosis. The
PreVILIG dataset did not access the severity of BPD, and
furthermore no prediction model with extensive ventila-
tor parameters could be validated after the third day of
life. However, the strength of the PreVILIG dataset is the
large number of included patients, with comparable
mean gestational age compared to the best five perform-
ing models, in an IPD database containing detailed in-
formation on clinical data and respiratory support
during the first week after birth. Even when the limita-
tions of this dataset are taken into account, those predic-
tion models that have adequate generalizability should
perform similarly in this dataset, as if it were a mixed
dataset of both ventilated and non-ventilated infants. To
assess the risk of bias due to non-randomly missing
values, the calculations were rerun after multiple impu-
tations. Overestimation of the discriminative perform-
ance due to this bias seems implausible, because these
analyses showed little change in the AUC values for each
model.
Third, although the appraisal of the 26 studies using
the STROBE criteria showed that the quality of these
studies ranged from moderate to excellent, this instru-
ment does not estimate the quality of any prognostic
study. It was developed merely to assess and improve
the quality of reporting observational research [18].
Therefore, it does not include items specified for the de-
sign and conduct of prognostic research, such as selec-
tion of predictors, handling of missing values, and internal
and external validation. Although a first initiative waspublished very recently [60], such an instrument is cur-
rently lacking. Therefore, we combined the STROBE
criteria with these other aspects of prognostic studies in
our evaluation.
Implications for practice and research
The results of this systematic review have several impli-
cations for future research. First, the international re-
search community urgently needs a quality assessment
instrument aimed at prediction model studies, similar to
those for the reporting of systematic reviews, random-
ized controlled trials, or observational studies [18,61,62].
In contrast with the former mentioned quality assess-
ment instruments, this instrument should address not
only reporting issues like the STROBE, but assess all the
different aspects of the development, validation and im-
plementation of a prediction model, as described in a
series of recently published articles [8-11,60].
Furthermore, the two promising models identified in
this systematic review should be confirmed by externally
validation using a more recent, large multicenter cohort,
preferably studied prospectively and including both ven-
tilated and non-ventilated preterm infants at different
points of postnatal life. In order to investigate potential
(new) interventions for preventing BPD, prediction
models should be developed at different time points
after birth to facilitate the evaluation of better targeted
interventions and should investigate whether risks for
the outcomes BPD and the combined outcome “death or
BPD” can be assessed using the same model or, instead,
need separate models. These models could then be re-
fined for example by adding genetic susceptibility as a
predictor [63]. However, more research is needed to de-
termine which of the suggested multiple candidate genes
will increase accuracy of a prediction model [64]. An-
other improvement in the clinical prediction models
could come from using birth weight Z scores in addition
to gestational age instead of combining gestational age
and birth weight in the model. Although these predictors
are both established risk factors for BPD, combining the
two might not improve the accuracy of the model due to
collinearity [52,58].
Any future model should report validation analyses,
showing both discriminating and calibration perform-
ance and handling missing values in the dataset by im-
putation, rather than exclusion [10,21,65]. If this study
reveals a model with sufficient performance, an inter-
national consensus conference should be held to deter-
mine the utility of this model and, guided by this, review
what variables – at any stage after birth - could improve
the prediction rule without neglecting the previous
model. This method is preferable to developing yet a
whole new model in isolation [22]. Finally, clear impact
of using that model should be provided by showing
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ventive interventions, and future trials investigating new
interventions on the important health outcome BPD.
Conclusion
This systematic review and external validation study
demonstrates that most of the numerous existing clinical
prediction models for BPD cannot be used in practice
because they are of low quality and their generalizability
is poorly assessed. Few studies have externally validated
these models, and no study previously assessed or pre-
sented model calibration. We have demonstrated that all
models show poor to moderate discriminative ability
and varying calibration for the prediction of the outcome
BPD, with the exception of two models from Ryan and
Laughon [31,40]. These deserve further evaluation and
refinement. To identify very preterm infants for inclu-
sion in future intervention studies aiming to reduce the
risk of BPD, additional variables will be required to in-
crease the predictive accuracy of these two models. Any
updated model should be externally validated and put to
a test of a proper impact analysis before its clinical
implementation.
Appendix
Query used for the systematic review
Electronic searches of MEDLINE (from 1966 till April
2012), EMBASE (from 1974 till April 2012) and
CINAHL (from 1982 till April 2012) were performed for
publications concerning prediction models for BPD in
preterm infants, using the following Medical Subject
Heading terms and text words:
(“neonatal chronic lung disease” OR “bronchopulmon-
ary dysplasia” OR “chronic lung disease of prematurity”)
AND (“predict” OR” prediction” OR “predictive value”
OR “prediction rule” OR “prognosis” OR “prognostic fac-
tor” OR “evaluation” OR “evaluation study” OR “risk fac-
tor” OR “risk assessment” OR “regression analysis” OR
“logistic model” OR “statistical model” OR “algorithm”
OR “multivariate analysis” OR” predictive value of tests”
OR “Area Under Curve” OR “Receiver Operator Curve”).
No search limits were used.
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